AACR Recognizes its Newest Grantees at 101st Annual Meeting 2010

Released: 13-Apr-2010 1:00 PM EDT
Source Newsroom: American Association for Cancer Research (AACR)
Contact Information

Available for logged-in reporters only

Newswise — The AACR would like to congratulate its newest grantees at the AACR 101st Annual Meeting 2010, held April 17-21.

FELLOWSHIPS:

AACR-Amgen, Inc. Fellowships in Clinical/Translational Cancer Research
• Sophia Adamia, Ph.D., Dana-Farber Cancer Institute
Genome-wide alternative splicing in AML-novel targets for antibody therapy
• Abdel Kareem Azab, Ph.D., Dana-Farber Cancer Institute
The role of hypoxia in the dissemination of multiple myeloma

AACR Anna D. Barker Fellowship in Basic Cancer Research
• Uddhav K. Shigdel, Ph.D., Harvard College
Crystallization of type IIA topoisomerase using covalent cross-linking

AACR-The ASCO Cancer Foundation Young Investigator Translational Cancer Research Award
• Aude G. Chapuis, M.D., Fred Hutchinson Cancer Research Center
Targeting melanoma with anti-CTLA-4 and NY-ESO-1-specific cytotoxic T cells

AACR-Astellas U.S.A. Foundation Fellowship in Basic Cancer Research
• Karen Vrijens, Ph.D., St Jude Children’s Research Hospital
Small molecule BMP agonists as therapeutic agents for brain tumors

AACR-Astellas U.S.A. Foundation Fellowship in Clinical/Translational Cancer Research
• Andrew C. Hsieh, M.D., University of California, San Francisco
Dissection of the downstream targets of the mTOR pathway in prostate cancer

AACR-AstraZeneca Fellowship for Translational Lung Cancer Research
• Timothy F. Burns, M.D., Ph.D., Johns Hopkins University, School of Medicine
The development of targeted therapeutic approaches in Kras mutant NSCLC

AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research
• Sameek Roychowdhury, M.D., Ph.D., University of Michigan
Gene fusions in myeloproliferative neoplasms

AACR Judah Folkman Fellowship for Anti-Angiogenesis Research
• Keli M. Turner, M.D., University of Maryland, Baltimore
Inhibition of IL-1 as a novel target in pancreatic adenocarcinoma

AACR-National Brain Tumor Society Fellowships, in memory of Bonnie Brooks
• Rebecca A. Ihrie, Ph.D., University of California, San Francisco
Developing a novel model of pediatric glioblastoma
• Fengting Yan, M.D., Ph.D., Ohio State University
Targeting protein arginine methyltransferase 5 in glioblastoma multiforme

FELLOWS GRANTS:

AACR-Colorectal Cancer Coalition Fellows Grant, in memory of Lisa Dubow
• Rona D. Yaeger, M.D., Memorial Sloan-Kettering Cancer Center
A translational study of inhibiting AKT to treat colorectal cancer

AACR-FNAB Fellows Grant for Translational Pancreatic Cancer Research
• Amy L. Collins, M.D., The Ohio State University
The role of stellate cells on MicroRNA expression in pancreatic cancer

CAREER DEVELOPMENT AWARDS:

AACR-Aflac, Incorporated, Career Development Award for Pediatric Cancer Research
• Zhe Li, Ph.D., Brigham and Women’s Hospital, Inc.
MicroRNA 125b-2 in Down syndrome megakaryocytic leukemia

AACR Centennial Career Development Awards for Childhood Cancer Research
• Mari H. Dallas, M.D., St. Jude Children’s Research Hospital
Dendritic cell facilitate thymic reconstitution after transplantation
• Christopher A. French, M.D., Brigham and Women’s Hospital, Inc.
Targeting the tumor epigenome in NUT midline carcinoma
• Dan Ruan, Ph.D., Stanford University
Image gently for pediatric image guided radiotherapy: a systematic study
• Narendra Wajapeyee, Ph.D., Yale University School of Medicine
Understanding the mechanism of BCR-ABL-mediated transformation

AACR-FNAB Career Development Award for Translational Cancer Research
• Arnold I. Chin, M.D., Ph.D., University of California, Los Angeles
Quantitative molecular and drug sensitivity analysis for bladder cancer

AACR Judah Folkman Career Development Award for Anti-Angiogenesis Research
• Marco Seandel, M.D., Ph.D., Weill Medical College of Cornell University
Blocking endothelial trophic support of chemoresistant genitourinary tumors

INDEPENDENT INVESTIGATOR GRANTS:

Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research
• Charles V. Clevenger, M.D., Ph.D., Northwestern University - Chicago Campus
Cyclophilin A as a target in breast cancer
• Wilson H. Miller Jr., M.D., Ph.D., Lady Davis Institute for Medical Research of the SMBD Jewish General Hospital
Targeting eIF4E with ribavirin in poor prognosis breast cancer


Download interviews with cancer researchers and recordings of the teleconferences by subscribing to the AACR Scientific Podcasts via iTunes (http://www.aacr.org/itunes) or an RSS Reader (http://www.aacr.org/rss).

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.


Comment/Share